Estimation of prevalence of gingival enlargement - a population- based study

Authors

  • KALAIVANI N.
  • DR. N.D. JAYAKUMAR
  • MAHESH RAMAKRISHNAN.

Keywords:

anticonvulsants, chronic and acute enlargement, calcium channel blocker, gingival enlargement, immunosuppressants, inflammation, Innovation

Abstract

Gingival enlargement is an increase in the size of the gingiva. It is also known as the gingival hyperplasia or hypertrophy. They can be categorised based on their etiology, pathogenesis, location, size and extent. Inflammatory gingival enlargement is a most common form and clinically present as soft and discolored gingiva. Drug induced gingival enlargement is a well recognised adverse effect of certain systemic medications. Calcium channel blockers, Anticonvulsants and Immunosuppressants are frequently implicated drugs in the etiology of drug induced enlargement. The aim of the study is to assess the prevalence of gingival enlargement and its distribution.

Objective:
  • To assess the prevalence of inflammatory and drug induced
  • To compare the prevalence of gingival enlargement in different age
  • To compare the prevalence of gingival enlargement in male and female.
  • To compare the prevalence of gingival enlargement in response to different types of

The study was a retrospective, University based study. Case sheets of patients visiting the dental outpatient ward June 2019 to March 2020 were collected. Patients diagnosed with gingival enlargement were sorted and tabulated in Microsoft excel sheet and analysed using SPSS software. In the present study, out of 40,000 patients, the prevalence of inflammatory enlargement was found to be 0.1% and the drug induced enlargement was 0.03%. Drug induced enlargement was more prevalent in males than in females, whereas inflammatory enlargement was more prevalent in females than males, there was no statistically significant difference in the prevalence rate between age groups (p= 0.362) and gender (p= 0.210). On comparing the drugs, phenytoin was consumed by one third of the population (43%) but had a higher prevalence rate of 65% than antihypertensive drugs (28% )and immunosuppressants (7% ).

Downloads

Download data is not yet available.

Downloads

Published

2020-08-30

How to Cite

KALAIVANI N., DR. N.D. JAYAKUMAR, & MAHESH RAMAKRISHNAN. (2020). Estimation of prevalence of gingival enlargement - a population- based study. The Journal of Contemporary Issues in Business and Government, 26(2), 309–315. Retrieved from https://cibgp.com/au/index.php/1323-6903/article/view/265

Issue

Vol. 26 No. 2 (2020): The journal of contemporary issues in business and government

Section

Articles

License

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.